 |
 |
 |
Dr. Reddy's to release Q1 FY09 results on July 21, 2008;
Earnings call slated for July 21, 6.30 PM IST/9.00 AM EST
Hyderabad, India, July 15, 2008: Dr. Reddy's Laboratories (NYSE: RDY) will announce results for the First Quarter ended June 30, 2008 on Monday, July 21, 2008 after the Board Meeting. The results will be available on the Company’s website www.drreddys.com
Summary of Events
| Event | Date and Time (IST) | Medium |
Release of financial results |
July 21, after the Board Meeting |
Email, Media, Company website, Businesswire |
Earnings Call |
July 21, 6.30 PM IST / 9.00 AM EST |
Hosted by the Company |
Webcast of Earnings Call |
July 21, 6.30 PM IST / 9.00 AM EST through July 21, 2008 |
URL available on Company’s website, www.drreddys.com |
Transcripts of the Earnings call |
Available on the Company’s website |
URL available on Company’s website, www.drreddys.com |
Earnings Call
Following the release, the management of the Company will host an earnings call to discuss the Company’s financial performance.
| Date | Timing | Dial-in number |
July 21, 2008 |
India – 6.30 PM |
Participants from India Participants from International |
No password/pin number is necessary to dial in to any of the other calls. As participation in the call is limited, early registration is encouraged. The operator will provide instructions on asking questions before and during the call.
Audio Webcast
The audio webcast of the earnings call will be available to all interested parties at www.drreddys.com. Please visit the web site at least fifteen minutes ahead of the scheduled start time to register and to download and install any necessary audio software. Participants in the webcast can listen to the proceedings, but will not be able to ask questions. The replay will be available 2 hours after the earnings call, through July 29, 2008. For play back dial in phone No:022 3065 1212 and ID: 375.
Transcript
The transcript of the earnings call will also be available on the Company's website.
About Dr Reddy’s
Established in 1984, Dr. Reddy’s Laboratories (NYSE: RDY) is an emerging global pharmaceutical company with proven basic research capabilities. The company develops, manufactures and markets a wide range of pharmaceutical products in India and overseas. Dr. Reddy’s produces finished dosage forms, active pharmaceutical ingredients, diagnostic kits, critical care and biotechnology products. The basic research program of Dr. Reddy’s focuses on cancer, diabetes, bacterial infections and pain management.
Website: http://www.drreddys.com
Contact
For further information please contact:
Investor Relations: Nikhil Shah (nikhilshah@drreddys.com) or on +91-40-66511532
